eISSN : 2146-9369
Creative Commons Lisansı
Journal of Clinical and Experimental Investigations is licenced under the terms of Creative Commons Attribution-Non Commercial4.0 International (CC BY-NC 4.0) License.
Abstract - Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox : A Case Report
Uğur Önal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Hüsnü Pullukçu, Sercan Ulusoy, Oğuz Reşat Sipahi

Uğur Önal, Meltem Taşbakan, Tansu Yamazhan, Bilgin Arda, Hüsnü Pullukcu,Sercan Ulusoy, Oğuz Reşat Sipahi

Ege University-Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Izmir/Turkey

Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report

ABSTRACT

In this paper, we present a 69 years old diabetic patient with mucormycosis who was succesfully treated with liposomal amphotericin B (LAMB), posaconazole and deferasirox despite having no adequate surgery. There was no relapse on 6 month post-treatment follow-up. We conclude that combination of antifungal antibiotics with deferasirox may be successful in the salvage therapy of mucormycosis especially in diabetic patients. J Microbiol Infect Dis 2016;6(1): 32-35

Onal U, Tasbakan M, Yamazhan T, Arda B, Pullukcu H, Ulusoy S, Sipahi OR. Treatment of Mucormycosis with Liposomal Amphotericin B, Posaconazole and Deferasirox: A Case Report, J Microbiol Infect Dis 2016;6(1):32-35 doi: 10.5799/ahinjs.02.2016.01.0211

Volume 06, Number 01 (2016)